Polygenic Scores in the Direct-to-Consumer Setting: Challenges and Opportunities for a New Era in Consumer Genetic Testing
Journal of Personalized Medicine · 23.03.2023 · 13 (4) · 573
DOI: 10.3390/jpm13040573 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 23.03.2023. Verfasst von Jin K Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, MA 02115, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Direct-to-consumer (DTC) genetic tests have generated considerable scholarly attention and public intrigue. Although the current consumer genetic testing regime relies on the reporting of individual variants of interest to consumers, there has recently been interest in the possibility of integrating polygenic scores (PGS), which aggregate genetic liability for disease across the entire genome. While PGS have thus far been extensively explored as clinical and public health tools, the use of PGS in consumer genetic testing has not yet received systematic attention, even though they are already in use for some consumer genetic tests. In this narrative review, we highlight the ethical, legal, and social implications of the use of PGS in DTC genetic tests and synthesize existing solutions to these concerns. We organize these concerns into three domains: (1) industry variation; (2) privacy and commercialization; and (3) patient safety and risk. While previously expressed concerns in these domains will remain relevant, the emergence of PGS-based DTC genetic tests raises challenges that will require novel approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harvard Medical School, Boston, MA 02115, USA.
- Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02115, USA.
- Kolling Institute, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, Sydney, NSW 2077, Australia.
- School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
Zitieren
APA
Park, J. K., & Lu, C. Y. (2023). Polygenic Scores in the Direct-to-Consumer Setting: Challenges and Opportunities for a New Era in Consumer Genetic Testing. Journal of Personalized Medicine, 13(4), 573. https://doi.org/10.3390/jpm13040573
Vancouver
Park JK, Lu CY. Polygenic Scores in the Direct-to-Consumer Setting: Challenges and Opportunities for a New Era in Consumer Genetic Testing. Journal of Personalized Medicine. 2023;13(4):573. doi:10.3390/jpm13040573
BibTeX
@article{Park2023,
author = {Park, Jin K and Lu, Christine Y},
title = {Polygenic Scores in the Direct-to-Consumer Setting: Challenges and Opportunities for a New Era in Consumer Genetic Testing},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {4},
pages = {573},
doi = {10.3390/jpm13040573}
}
EUVIMED